The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 12 Salvia officinalis (Sage)-derived ingredients as used in cosmetic formulations. These ingredients are most commonly reported to function as skin conditioning agents and fragrance ingredients. Because final product formulations may contain multiple botanicals, each containing the same constituents of concern, formulators are advised to be aware of these constituents and to avoid reaching levels that may be hazardous to consumers. With Salvia officinalis (Sage)-derived ingredients, the Panel was concerned about certain terpenes as potential sensitizers. Industry should use current good manufacturing practices to minimize impurities. The Panel reviewed data relevant to the safety of these ingredients in cosmetic formulations, and concluded that 6 of the ingredients (those derived from the leaves and the oil) are safe in cosmetics in the present practices of use and concentrations described in this safety assessment when formulated to be non-sensitizing, and that the data are insufficient to make a determination of safety for the remaining 6 ingredients under the intended conditions of use in cosmetic formulations.
Research Institute for Fragrance Materials (RIFM). Sage Oil, Dalmatian. In: OpdykeDLJ, ed. Monographs on Fragrance Raw Materials: A Collection of Monographs Originally Appearing in Food and Cosmetics Toxicology. Pergamon Press; 1979:672.
3.
KarlbergALepoittevinJP. One hundred years of allergic contact dermatitis due to oxidized terpenes: what we can learn from old research on turpentine allergy. Contact Dermat. 2021;85(6):627-636.
JakovljevićMJokicSMolnarM, et al.Bioactive profile of various Salvia officinalis L. preparations. Plants. 2019;8(3):55.
8.
GhorbaniAEsmaeilizadehM. Pharmacological properties of Salvia officinalis and its components. J Tradit Complement Med. 2017;7(4):433-440.
9.
SharmaYFaganJSchaeferJ. Ethnobotany, phytochemistry, cultivation and medicinal properties of Garden sage (Salvia officinalis L.). J Pharmacogn Phytochem. 2019;8:3139-3148.
10.
MartinsNBarrosLSantos-BuelgaCHenriquesMSilvaSFerreiraIC. Evaluation of bioactive properties and phenolic compounds in different extracts prepared from Salvia officinalis L. Food Chem. 2015;170:378-385.
11.
Solabia. Specifications data sheet Glycolysat of Sage UP (Salvia Officinalis (Sage) Leaf Extract). (Unpublished data submitted by the Personal Care Products Council on April 1, 2021); 2009.
12.
Anonymous. Salvia Officinalis (Sage) Leaf Extract (method of manufacture, impurities and specifications). (Unpublished data submitted by Personal Care Products Council on December 10, 2020); 2020.
13.
Anonymous. Summary Information Salvia Officinalis (Sage) Leaf Extract. (Unpublished data submitted by Personal Care Products Council on January 5, 2021); 2021.
14.
MehdizadehTHashemzadehMNazarizadehA, et al.Chemical composition and antibacterial properties of Ocimum basilicum, Salvia officinalis and Trachyspermum ammi essential oils alone and in combination with nisin. Res J Pharmacogn. 2016;3(4):51-58.
15.
Solabia. Specifications data sheet Vegebios of Sage 1.5P (Salvia Officinalis (Sage) Leaf water). (Unpublished data submitted by the Personal Care Products Council on April, 2021); 2009.
16.
StojanovicDLakušićBRistićMSlavkovskaVLakusicD. Variations in essential oil yields and compositions of Salvia officinalis (Lamiaceae) at different developmental stages. Bot Serb. 2013;37:127-139.
17.
WalchSGTinzohLNZimmermannBFStühlingerWLachenmeierDW. Antioxidant capacity and polyphenolic composition as quality indicators for aqueous infusions of Salvia officinalis L. (sage tea). Front Pharmacol. 2011;2:79.
18.
ToberCSchoopR. Modulation of neurological pathways by Salvia officinalis and its dependence on manufacturing process and plant parts used. BMC Compl Alternative Med. 2019;19(1):128.
19.
BaranauskieneRDambrauskienėEVenskutonisRViskelisP. Influence of harvesting time on the yield and chemical composition of Sage (Salvia officinalis L.). Conference proceedings presented at: FoodBalt; May 5-6, 2011; Kaunas, Lithuania. pp. 104-109.
20.
ArraizaMArrabalCLópezJV. Seasonal variation of essential oil yield and composition of sage (Salvia officinalis L.) grown in Castilla - La Mancha (Central Spain). Not Bot Horti Agrobot Cluj-Napoca. 2012;40:106-108.
21.
BrancatoABroccaDLentdeckerC, et al.Modification of the existing maximum residue levels for ametoctradin in herbs and edible flowers. EFSA J. 2017;15(9):e04869.
22.
European Food Safety Authority (EFSA). Reasoned opinion on the modification of the existing MRLs for ametoctradin in sage and basil. EFSA J. 2015;13(6):4153.
23.
SzpyrkaESłowik-BorowiecM. Consumer health risk to pesticide residues in Salvia officinalis L. and its infusions. J Environ Sci Health B. 2019;54(1):14-19.
24.
AfonsoAFPereiraORFernandesÂ, et al.Phytochemical composition and bioactive effects of Salvia africana, Salvia officinalis ‘icterina’ and Salvia mexicana aqueous extracts. Molecules. 2019;24(23):4327.
25.
CraftJDSatyalPSetzerWN. The chemotaxonomy of common sage (Salvia officinalis) based on the volatile constituents. Medicine. 2017;4(3):47.
U.S. Food and Drug Administration Center for Food Safety & Applied Nutrition (CFSAN). Voluntary Cosmetic Registration Program - frequency of Use of Cosmetic Ingredients (VCRP). (Obtained under the Freedom of Information Act from CFSAN; requested as “Frequency of Use Data” January 4, 2022; received January 11, 2022); 2022.
28.
Personal Care Products Council. Concentration of use by FDA product category: sage-derived ingredients. (Unpublished data submitted by Personal Care Products Council on February 26, 2020); 2020.
29.
Personal Care Products Council. Concentration of use by FDA product category: Salvia Officinalis (Sage) Leaf Oil. (Unpublished data submitted by Personal Care Products Council on October 27, 2020); 2020.
GrdišaMJug-DujakovićMLončarićM, et al.Dalmatian Sage (Salvia officinalis L.): a review of biochemical contents, medical properties and genetic diversity. Agric Conspectus Sci. 2015;80(2):69-78.
32.
RodriguesMRAKanazawaLKSdas NevesTLM, et al.Antinociceptive and anti-inflammatory potential of extract and isolated compounds from the leaves of Salvia officinalis in mice. J Ethnopharmacol. 2012;139(2):519-526.
33.
SabryMMAbdel-RahmanRFEl-ShenawySMHassanAMEl-GayedSH. Estrogenic activity of Sage (Salvia officinalis L.) aerial parts and its isolated ferulic acid in immature ovariectomized female rats. J Ethnopharmacol. 2022;282:114579.
34.
MonsefiMAbedianMAzarbahramZAshrafMJ. Salvia officinalis L. induces alveolar bud growing in adult female rat mammary glands. Avicenna J Phytomed. 2015;5(6):560-567.
35.
DomarackýMRehákPJuhásŠKoppelJ. Effects of selected plant essential oils on the growth and development of mouse preimplantation embryos in vivo. Physiol Res. 2007;56(1):97-104.
36.
ZaniFMassimoGBenvenutiS, et al.Studies on the genotoxic properties of essential oils with Bacillus subtilis rec-assay and Salmonella/microsome reversion assay. Planta Med. 1991;57(3):237-241.
37.
IshidateMJrSofuniTYoshikawaK, et al.Primary mutagenicity screening of food additives currently used in Japan. Food Chem Toxicol. 1984;22(8):623-636.
38.
De MartinoLDe FeoVNazzaroF. Chemical composition and in vitro antimicrobial and mutagenic activities of seven Lamiaceae essential oils. Molecules. 2009;14(10):4213-4230.
39.
VujosevicMBlagojevićJ. Antimutagenic effects of extracts from sage (Salvia officinalis) in mammalian system in vivo. Acta Vet Hung. 2004;52(4):439-443.
40.
ZareH. Effects of Salvia officinalis extract on the breast cancer cell line. Sci Med Journ. 2019;1(1):25-29.
41.
RíoÁGSanzJColomaAG, et al.Cytotoxic activity of ±-humulene and transcaryo-phyllene from Salvia officinalis in animal and human tumor cells. An R Acad Nac Farm. 2010;76(3):343-356.
42.
LoizzoMTundisRMenichiniFSaabAStattiGMenichiniF. Cytotoxic activity of essential oils from Labiatae and Lauraceae families against in vitro human tumor models. Anticancer Res. 2007;27(5A):3293-3299.
43.
TisserandRYoungR. Essential Oil Safety: A Guide for Health Care Professionals. 2nd ed.Churchill Livingston, Elsevier; 2014.
44.
Anonymous. Clinical safety evaluation repeated insult patch test (product contains 0.005% Salvia officinalis (Sage) leaf extract (1% dilution tested)). (Unpublished data submitted by the Personal Care Products Council on April 29, 2021); 2017.
45.
Anonymous. Repeated insult patch test (body lotion containing 0.03% Salvia Officinalis (Sage) Oil). (Unpublished data submitted by the Personal Care Products Council on April 29, 2021); 2000.
46.
MayerEGescheidt-ShoshanyHWeltfriendS. Allergic contact dermatitis caused by Salvia officinalis extract. Contact Dermat. 2011;64(4):237-238.
47.
SelvaagEHolmJOThuneP. Allergic contact dermatitis in an aroma therapist with multiple sensitizations to essential oils. Contact Dermat. 1995;33(5):354-355.
48.
JirovetzLBuchbauerGDenkovaZSlavchevAStoyanovaASchmidtE. Chemical composition, antimicrobial activities and odor descriptions of various Salvia sp. and Thuja sp. essential oils. Nutrition-Vienna. 2006;30(4):152.
